These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7996543)

  • 1. Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.
    Minor DL; Wyrick SD; Charifson PS; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1994 Dec; 37(25):4317-28. PubMed ID: 7996543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
    J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.
    Charifson PS; Wyrick SD; Hoffman AJ; Simmons RM; Bowen JP; McDougald DL; Mailman RB
    J Med Chem; 1988 Oct; 31(10):1941-6. PubMed ID: 3050089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
    Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
    J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
    Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
    Berger JG; Chang WK; Clader JW; Hou D; Chipkin RE; McPhail AT
    J Med Chem; 1989 Aug; 32(8):1913-21. PubMed ID: 2666667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
    Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
    J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Izenwasser S; Geter-Douglass B; Witkin JM; Newman AH
    J Med Chem; 1995 Oct; 38(21):4284-93. PubMed ID: 7473556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
    Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
    J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, conformation, and dopaminergic activity of 5,6-ethano-bridged derivatives of selective dopaminergic 3-benzazepines.
    Weinstock J; Oh HJ; DeBrosse CW; Eggleston DS; Wise M; Flaim KE; Gessner GW; Sawyer JL; Kaiser C
    J Med Chem; 1987 Aug; 30(8):1303-8. PubMed ID: 2886663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
    Negash K; Nichols DE; Watts VJ; Mailman RB
    J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
    Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
    Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB; Lawlor M; Dunne A; O'Boyle KM
    J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
    Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
    J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ; Chen LJ; Jin GZ; Creese I
    Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.